Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Vandoeuvre Les Nancy Cedex, France Clinical Trials

A listing of Vandoeuvre Les Nancy Cedex, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Synergism of Immunomodulation and Tumor Ablation

This is a single-arm, open-label, multi-center early phase II study. This proof of concept study will investigate whether the combined use of local tumor ablation/radiation plus immunomodulating drugs may induce a significant immune response in patient with incurable liver metastases from colorectal cancer (CRC) (+/- limited extrahepatic disease) being stable ...

Phase

0.0 miles

Learn More »

Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects

The purpose of this study is to evaluate itacitinib in combination with corticosteroids for the treatment of Grades II to IV acute graft-versus-host disease (aGVHD) in steroid-naive pediatric participants.

Phase

0.31 miles

Learn More »

UNUSUAL TOXICITY INDUCED BY RADIOTHERAPY STUDY

In order to evaluate the physiopathological knowledge of the different pathological manifestations associated with individual radiosensitivity, it seems essential to carry out this pilot study. It has agglomerated homogeneous tissue samples to identify new biomarkers for patient diagnosis and follow-up, and may predict the therapeutic response. These knowledge will help ...

Phase N/A

0.67 miles

Learn More »

Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects ( 45 Years) Hospitalized for an Ischaemic Stroke

Incidence of strokes has increased these last 20 years in young population. This rise could be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been descripted as a potential factor of reversible vasoconstriction. The main objective is to show that an exhaustive assessment of a stroke ...

Phase N/A

2.19 miles

Learn More »